Angiogenesis
Findings from Kyung-Hee University advance knowledge in angiogenesis
Published in Drug Week, November 17th, 2006
A report, "Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities," is newly published data in Carcinogenesis. According to a study from Korea, "Vitis amurensis Rupr. (Vitaceae) has long been used in Chinese/Oriental herbal medicine for the treatment of cancer, but its active compounds and mechanisms of action have not been well studied. To this end, we isolated from its root heyneanol A (HA), which is a tetramer of resveratrol (RES), and established the in vivo antitumor activity of HA using the mouse Lewis lung carcinoma (LLC) model."
"We administered HA and RES by daily...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-11-17)
More Articles from Drug Week
- Amyotrophic Lateral Sclerosis
Avicena completes patient enrollment for ALS-08 phase II clinical trial - Drug Development
Avi presents successful data using Neugene antisense to alter drug metabolism in humans - Influenza Vaccine
Intranasal flu vaccine produces higher antibody responses in young children than injectable - Market Analysis
U.S. market for psoriasis therapeutics to surpass $9 billion by 2016 - Arrhythmia Therapy
Research from Bico, Department of Statistics broadens understanding of arrhythmia therapy - Aspergillosis Therapy
Research on aspergillosis therapy published by scientists at University of Michigan, Department of Internal Medicine - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
